Scanning Electron Microscope Market is anticipated to propel industry growth over the forecast period

The global scanning electron microscopes market is expected to reach USD 2.9 billion by 2022, according to a new report by Grand View Research Inc. Rapidly growing semiconductor industry leads to rising demand of microscopes in procedures such as lithography, coating, failure analysis and element detection. Increasing demand in application areas of semiconductor industry such as miniature transistor chips and quantum dots are further expected to drive market growth over the forecast period.


The rising demand for research in nanotechnology, which essentially requires technologically advanced and high-resolution microscopes along with the presence of favorable government funding in support of R&D innovation are anticipated to propel market growth over the forecast period.

For instance, the National Institute of Health (NIH) is granting a huge amount to the University of California (UC), Berkeley under the initiative termed as BRAIN (President Barak Obama’s Brain Research through Advancing Innovative Neurotechnologies).

To request a sample copy or view summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/scanning-electron-microscope-market

Further key findings from the study suggest:

• Application of SEM in pharmaceuticals is expected to account for over 30% share by 2022 owing to, the increasing prevalence of chronic diseases leading to increased R&D expenditure and demand for digital microscopes in the fields of life sciences and medicine.
• Application of SEM in automobiles is expected to grow at a lucrative CAGR of over 11.0% over the forecast period. Increasing demand of SEM in surface observation, film thickness analysis and coating analysis is expected to drive demand.
• Asia Pacific is expected to dominate the market by 2022 at over 35.0%, due to the presence of world class manufacturers for scanning electron microscopes in this region and increasing usage of SEM for elemental analysis and imaging.
• Growing demand for advanced scanning electron microscopes for the range of material research is expected to boost the SEM market in Latin America which is expected to grow at a CAGR of 11.6% over the forecast period.
• Furthermore, the presence of favorable funding initiatives by government accelerates R&D in various industries such as pharmaceutical, semiconductor and automobiles.
• Some key players of this market include Bruker Corporation, Danish Micro Engineering (DME), FEI Company, Hitachi High Technologies Corporation, JEOL Ltd., Leica Microsystems, Nanoscience Instruments, Inc., Nikon Corporation, Olympus Corporation, Tescan Orsay Holding and Carl Zeiss.
• The extensively adopted strategic initiative by key players includes substantial investment in R&D of SEMs. According to the U.S. National Nanotechnology Initiative, public investment in nanotechnology grew from zero in 2000 to approximately USD 65 billion in 2011.
• New product launches such as out-lens type thermal-electron gun scanning electron microscope by Hitachi High Technologies Corporation is also likely to serve as a viable sustainability strategy.

See More Reports of This Category:
http://www.grandviewresearch.com/industry/medical-devices

About Grand View Research:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact:

Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: www.grandviewresearch.com

Genomics In Cancer Care Market is expected to reach USD 9.22 billion by 2022

Global genomics in cancer care market is expected to reach USD 9.22 billion by 2022, according to a new report by Grand View Research, Inc. Increasing prevalence of cancer coupled with adoption of next generation sequencing for the diagnosis & treatment is expected to fuel the market with future growth opportunities. Increasing incidences of cancer triggers the demand for cost effective and accurate diagnostics in coming years. 

In addition, increasing demand for personalized medicines in molecular characterization of cancer to identify therapeutic targets is the factor attributing towards the market growth. Similarly, factors such as cost reduction in genome sequencing, growing healthcare expenditure levels and development of effective diagnostics & therapeutic procedures for cancer are responsible for the potential growth of genomics in cancer care.

To request a sample copy or view summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/genomics-in-cancer-care-market

Further key findings from the study suggest:

• Instrument segment dominated the overall market in terms of revenue share as of 2014 and accounted for 33.4% of market owing to high cost associated with it. Whereas, consumables are most widely used product segment in genome testing as they are indispensible component and frequently required to perform the test.
• Demand for services such as next generation sequencing, PCR and other such as cancer risk management & genetic testing are expected to grow over the forecast period due to increasing outsourcing activities to perform genome analysis. High cost of performing genetic tests and growing awareness pertaining to associated benefits with the use of these technologies are high impact rendering drivers for this segment.
• Drug discovery and development segment is expected to show lucrative CAGR of 17.6% during the forecast period owing to increasing demand for effective treatment for cancer and growing investment in biomedicines by manufacturers for the development of novel products. 
• Genome sequencing held the dominant share of technology segment as it is most prominently used for diagnosis due to associate benefits such as faster and accurate method. It is expected to show significant growth rate of 17.5% in coming years owing to remarkable decrease in the cost for genome sequencing and increasing adoption rates.
• The cancer research segment held the largest share of 34.1% in 2014 due to increasing demand for faster & accurate diagnostic methods to treat variety of cancer. Other use such as commercial adoption of genetic testing is expected to be fastest growing segment owing to increasing demand of cancer genomic testing to fulfill unmet needs in healthcare sector.
• Some key players operating in this market include Beckman Coulter Inc., Illumina, Inc, Affymetrix, Roche Diagnostics, Agilent Technologies, Cancer Genetics Inc., Danaher Corporation, Bio-Rad Labs, Pacific Biosciences, Quest Diagnostics, Sigma Aldrich, Luminex, Thermo Fisher scientific, Oxford Gene Technology., PerkinElmer, Qiagen, and GE Healthcare.

See More Reports of This Category:

http://www.grandviewresearch.com/industry/biotechnology

About Grand View Research:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: www.grandviewresearch.com

Healthcare Cognitive Computing Market is expected to reach nearly USD 5,064.8 million by 2022

Global healthcare cognitive computing market is expected to reach nearly USD 5,064.8 million by 2022, according to a new report by Grand View Research, Inc. Key factors attributing to the market growth are rapid growth in the scientific database, demand for personalized healthcare, and the need to reduce healthcare expenditure levels. Increasing geriatric population is a major factor increasing the prevalence rate of several diseases.

Information technology and big data analytics penetration in the healthcare industry is presently very less, and to tackle the increasing healthcare expenditure and improve customer experience, many manufacturers and research organizations are actively collaborating with technology firms to improve their products and services.

In 2015, big healthcare firms such as Johnson and Johnson (J&J) and Medtronic have partnered with IBM to utilize its cognitive computing platform Watson. J&J plans to utilize Watson to create a personal concierge service which can be used to prepare patients for knee surgery. Medtronic will use Watson to develop an internet of things (IOT) platform around its medical devices to collect data from patient’s personal use to understand product performance and patient response.

Furthermore, Apple has also invested significantly in the Watson platform to develop an IOS vendor ecosystem for its HealthKIT and ReasearchKit tool systems. These vendors would develop apps and other systems for personal health data collection, and utilizing the data for clinical trials and other healthcare applications.

In 2014, the natural language processing technology market accounted for the largest share at 46.5%, due to its ability to learn natural language key words, and different languages, thereby enabling easy user interface. Additionally, platforms such as IBM Watson are enabling the new startups to collaborate and develop new mobile and cloud applications. However, automated reasoning is expected to be the fastest growing with a over the forecast period, owing to its ability to apply logical reasoning and solve complex problems.

To request a sample copy or view summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/healthcare-cognitive-computing-market

Further key findings from the study suggest:

• North America dominated the overall market with a share of nearly 52%. Key reasons attributing to region's market position include collaboration between information technology firms and healthcare firms and research centers. The convergence of these two industries is leading to reduction in the overall healthcare expenditure, in solving complex medical problems and drug discovery.
• Asia Pacific is identified as the fastest growing market. This region is expected to witness high public and private investment in the healthcare sector to cater to the unmet medical needs. Owing to the advent of digital healthcare services; the providers in this region are supporting the use of advanced analytical tools to simplify the DNA analysis, patient history and other records as a part of personalized healthcare services.
• Key players operating in the market include Google, IBM, Apple, PTC, Palantir, Microsoft and others. These companies have invested heavily in the natural language processing and machine learning platforms to develop new products catering to the healthcare industry. Additionally, new startups working on these platforms are expected to intensify competition and eventually lead to market consolidation.

See More Reports of This Category:

http://www.grandviewresearch.com/industry/healthcare-it

About Grand View Research:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: www.grandviewresearch.com

Earthmoving Equipment Market is expected to escalate demand significantly over the coming years

The global earthmoving equipment market is expected to reach USD 184.56 billion by 2022, according to a new study by Grand View Research, Inc. Technological advancements such as facilitation of real-time monitoring for detecting and monitoring equipment failure are anticipated to fuel product demand.

Vendors are increasingly investing in R&D to develop solutions in order to improve machine operations.
Technology products such as AccuGrade Grade Control System and Computer Aided Earthmoving System (CAES) are increasingly being incorporated. Manufacturers also offer products with GPS technology and other electronic control modules and database tools for enhancing product offering.

Increasing mechanization of construction processes coupled with strong economic growth in Asia Pacific earthmoving machinery market is anticipated to boost consumption in the region. Rising expenditure on infrastructure activities is also expected to escalate demand significantly over the coming years.

To request a sample copy or view summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/earthmoving-equipment-market

Further key findings from the study suggest:

• Loaders segment accounted for over 45% of the overall consumption in 2014 and is expected to shrink over the next seven years. Demand balancing is anticipated to take some time as the industry is expected to continue to be serviced with large number of existing units.
• Excavators market was valued over USD 30 billion in 2014 and is expected to exhibit high growth over the forecast period. Escalating demand across broad residential applications such as public and private infrastructure development would drive demand extensively. Rising adoption in the commercial sector is another key factor driving industry growth.
• Construction equipment industry is expected to reach over USD 100 billion by 2022. Strong economic growth coupled with increasing consumer spending on infrastructure activities is anticipated to fuel product demand over the forecast period.
• Private construction spending accounted for over 75% of the total construction industry spending in 2014. Increasing government investment in infrastructure development particularly in developing nations of Asia Pacific is expected to spur demand. Growing urbanization paired with increasing demand from corporate sector for infrastructure development may also drive industry growth.
• Asia Pacific earthmoving equipment market accounted for over 50% of the industry share in 2014 and is estimated to exhibit high growth prospects over the next seven years. Emergence of lease-based machinery along with private investment in real estate is further expected to propel demand.
• Middle East earthmoving equipment market is expected to grow at a CAGR of over 9.5% from 2015 to 2022. Growing large scale construction projects especially in the Middle East countries is expected to increase demand for these products over the next few years. Technological advancements and improvement in the quality and after-market services offered by vendors is also anticipated to drive industry growth.
• Key competitors dominating the earthmoving equipment industry include Doosan Infracore Ltd., Caterpillar, Komatsu Ltd., Sany Heavy Industries Co. Ltd and Liebherr. Industry participants emphasize on offering low cost products over energy-efficient products, particularly in price sensitive markets. Manufacturers also focus on lowering production cost and meet emission regulations set by the various regulatory bodies. Chinese manufacturers are increasing their international presence in the wheel loaders industry, competing with enormous array of manufactures in this segment.

See More Reports of This Category:

http://www.grandviewresearch.com/industry/hvac-and-construction-technologies

About Grand View Research:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: www.grandviewresearch.com